Dana dhuwit saben siji saham Autolus Corp (AUTL)

Simbol lan logo merek Autolus Corp (AUTL)

Autolus Therapeutics (AUTL) leads the development of programmable CAR-T therapies, which underscores the importance of the cash per share metric illustrated by this chart from the GURU.Markets system. Meanwhile, 0.94 represents the latest level. The company is diversifying its research across various tumor types while maintaining an impeccable reputation and high trust within the global medical community.

AUTL Autolus Therapeutics PLC: Dhuwit awis saben siji saham ing interval 04.07.2022 - 20.11.2026

Rincian metrik komprehensif lan analitis Autolus Therapeutics plc (AUTL)

- rega pasar lan target rega analis:
- data dhuwit lan arus kas:
Ringkesan analisis perusahaan:AUTL (Autolus Corp)
Produk dadi autolus.com

This metric is calculated as the ratio of total cash and cash equivalents to the total number of shares, measuring internal liquidity and the financial safety cushion per share. Analyzing cash per share is critical for Autolus Therapeutics (AUTL), as the capital-intensive deployment of certified cell therapy centers requires significant reserves to navigate stringent regulatory oversight.